Lindab International AB (0MWK)
London Exchange · UK · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 132.90 |
|---|---|
| 52-week range | 118.15 – 245.20 |
| Return, 1 month / 3 months | +7.4% / +10.6% |
| Return, 1 year / 3 years | −34.2% / +2.1% |
| Trend | Below its 200-day average |
| RSI (14) | 64 |
| Volatility (1 year) | 31.7% |
| Worst drawdown (1 year) | -49.1% |
| Average daily value traded | 1.42M SEK |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lindab International AB makes ventilation products and building systems for the construction industry. Its range covers ducting and fittings, air handling units, and steel profiles used in roofing and walling, along with related components for indoor climate and building envelopes. Customers are mainly contractors, installers and builders active in ventilation and construction projects. The company is based in Sweden and operates across Europe, supplying products for both new construction and renovation work.
The shares are listed on the London Exchange in UK under the code 0MWK, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lindab International AB (0MWK) trades on the London Exchange in UK. It last closed at SEK 132.90 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,612 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.2% and over the last three months it rose 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 20 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.6% | ||
| From 52-week high | -44.9% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 10.6% | ||
| 6-month return | -14.4% | ||
| 12-month return, skipping the last month | -38.8% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.1% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.42M SEK | ||
| Zero-volume days | 15.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | +7.4% |
| 3 months | +10.6% |
| 6 months | −14.4% |
| 1 year | −34.2% |
| 3 years | +2.1% |
| 5 years | −39.9% |
Signals
| 50-day / 200-day average | 126.09 / 145.38 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 26.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | SEK 2.8000 |
| 31 Oct 2025 | SEK 2.7000 |
| 14 May 2025 | SEK 2.7000 |
| 31 Oct 2024 | SEK 2.7000 |
| 15 May 2024 | SEK 2.7000 |
| 3 Nov 2023 | SEK 2.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.